RxDoctor Payments Data

Usman Siddiqui, MD

Hospitalist · Nyack, NYNPI 1356774491

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $41,828 of the $69,643 with a category attached, or 60.1%. Abbott accounts for 95.3% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $26,880, 4.6 times the $5,864 reported in 2020. Among hospitalist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$69,643in general payments, 2019–2025

Across 48 payments — averaging $1450.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$66K
  • GE HealthCare$3K
  • Novo Nordisk$22
  • Medtronic$22
  • Biosense Webster, Inc.$12

What the payments were for

  • Consulting fees$41,82860%
  • Speaking & faculty fees$17,73025%
  • Travel & lodging$9,88514%
  • Food & beverage$2000%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott43$66,367
GE HealthCare2$3,220
Novo Nordisk1$22
Medtronic1$22
Biosense Webster, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$69,643 in reported general payments places this provider in the 95th percentile of 1,860 hospitalist providers in New York.

See all hospitalist providers in New York

Medicare billing

Part B allowed, 2024
$132,277
Medicare patients
321
Services billed
1,179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban27$18,409
Amlodipine-Valsartan-HctzAmlodipine/Valsartan/Hcthiazid17$6,488
Atorvastatin Calcium109$1,044
Valsartan25$799
Albuterol Sulfate HfaAlbuterol Sulfate14$681
Amlodipine Besylate101$633
Pantoprazole Sodium45$624
Rosuvastatin Calcium27$403
Gabapentin35$403
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide13$401
Metoprolol Succinate25$373
Levothyroxine Sodium25$346
Tamsulosin Hcl35$337
Mirtazapine15$313
Lisinopril44$282

Paid to pharmacies, not to this prescriber.

Other hospitalist in Nyack

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →